PT - JOURNAL ARTICLE AU - Belfin, R V AU - Bródka, Piotr AU - Radhakrishnan, B L AU - Rejula, V TI - COVID-19 peak estimation and effect of nationwide lockdown in India AID - 10.1101/2020.05.09.20095919 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.09.20095919 4099 - http://medrxiv.org/content/early/2020/05/13/2020.05.09.20095919.short 4100 - http://medrxiv.org/content/early/2020/05/13/2020.05.09.20095919.full AB - There was a fury of the pandemic because of novel coronavirus (2019-nCoV/SARS-CoV-2) that happened in Wuhan, Hubei province, in China in December 2019. Since then, many model predictions on the COVID-19 pandemic in Wuhan and other parts of China have been reported. The first incident of coronavirus disease 2019 (COVID-19) in India was reported on 30 January 2020, which was a student from Wuhan. The number of reported cases has started to increase day by day after 30 February 2020. The purpose of this investigation is to provide a prediction of the epidemic peak for COVID-19 in India by utilizing real-time data from 30 February to 14 April 2020. We apply the well-known epidemic compartmental model “SEIR” to predict the epidemic peak of COVID-19, India. Since we do not have the complete detail of the infective population, using the available infected population data, we identify the R0 by using polynomial regression. By using the third-order polynomial equation, we estimate that the basic reproduction number for the epidemic in India is R0 = 3.3 (95%CI, 3.1–3.5), and the epidemic peak could be reached by September 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by Polish National Science Centre, decisions no. 2016/21/D/ST6/02408 and Wrocław University of Science and Technology statutory funds.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the manuscript has been taken from the Internet sources. https://www.mohfw.gov.in/ https://www.worldometers.info/coronavirus/ https://www.who.int/emergencies/diseases/novel-coronavirus-2019